Tara Gurung

About

Tara Gurung is a leading health services researcher whose work has fundamentally shaped the evidence base for surgical decision-making in prostate cancer care. Her research centers on health technology assessment, systematic review methodology, and the comparative effectiveness of surgical interventions. Gurung’s landmark 2012 systematic review and economic modelling study, cited over 250 times, provided the first comprehensive evaluation of the clinical benefit and cost-effectiveness of laparoscopic versus robot-assisted radical prostatectomy for localized prostate cancer. This work was pivotal in informing national treatment guidelines and resource allocation decisions. She extended this analysis in her 2013 mixed treatment comparison meta-analysis, which systematically compared robot-assisted, standard laparoscopic, and open surgical approaches, offering crucial insights into their relative effectiveness. By rigorously synthesizing complex clinical and economic data, Gurung has empowered clinicians, policymakers, and patients with the evidence needed to navigate the rapidly evolving landscape of minimally invasive surgery. Her contributions remain essential reading for anyone studying surgical outcomes or health economics in urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.

   253 citations · 2012
2. 2
   Relative effectiveness of robot‐assisted and standard laparoscopic prostatectomy as alternatives to open radical prostatectomy for treatment of localised prostate cancer: a systematic review and mixed treatment comparison meta‐analysis

   96 citations · 2013

Key Collaborators

Contact & Links